<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01188525</url>
  </required_header>
  <id_info>
    <org_study_id>C09-04</org_study_id>
    <secondary_id>2009-014866-24</secondary_id>
    <nct_id>NCT01188525</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic Study to Characterize Individual Metabolic Profile</brief_title>
  <acronym>CIME1</acronym>
  <official_title>Pharmacokinetic of Ten Parent Drugs and Their Metabolits in Order to Characterise Individual Metabolic Profile</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nuclear Energy Commission (CEA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to descibe the pharmacokinetics of 10 substrates of enzymes involved in drug
      metabolism and their metabolites, after administration singly and simultaenously at
      predefined doses in 10 health volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to test the administration of combination of substrates and thereby
      to characterise simultaneously the main enzymes and transporters involved in drug metabolism.
      The doses of substrates administered will first assessed in terms of safety and their
      appropriateness for determination of pharmacokinetic parameters. Ten volunteers will be used,
      this number having been defined in view of the aims of this proof-of-concept pilot
      study,ie,safety and determination of pharmacokinetic parameters. The number was not the
      result of statistical calculation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pharmacokinetic parameters</measure>
    <time_frame>one week</time_frame>
    <description>The aim endpoint is based on the main pharmacokinetic parameters of each subject for all substrates and all metabolites. These main parameters are the area under the curve (AUC), the maximum concentration (Cmax), the half-life (T1/2)and the ratios of AUCs of the substrate and metabolites</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance of the concomittant administration of the 10 drugs: 1/number of volunteers with grade 4 adverse events 2/ number of volunteers with any adverse event, (grade 1 to grade 4)</measure>
    <time_frame>one week</time_frame>
    <description>All clinical and biological adverse events will be recorded within the 7 days following drug administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pharmacokinetic</measure>
    <time_frame>one week</time_frame>
    <description>To determine which sampling times will provid the most pharmacokinetic information on the most compounds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genotypes</measure>
    <time_frame>one month</time_frame>
    <description>Depending on the genotypes of the volunteers included, to evaluate the influence of these genotypes ont he pharmacokinetics of the substrates and their metabolites</description>
  </secondary_outcome>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy Volunteers</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>10 parents drugs adminstration</intervention_name>
    <description>A single and concomittant administration of 10 parent drugs will be performed: Acetaminophene, cafeine, dextrometorphan, digoxin, memantine,midazolam, omeprazole, repaglinide, rosuvastatine, tolbutamide.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy volunteers

        Exclusion Criteria:

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DUVAL Xavier, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of clinical investigation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center of clinical investigation</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2010</study_first_submitted>
  <study_first_submitted_qc>August 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2010</study_first_posted>
  <last_update_submitted>May 14, 2012</last_update_submitted>
  <last_update_submitted_qc>May 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pharmacokinetics</keyword>
  <keyword>enzymes</keyword>
  <keyword>metabolism prediction</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

